Public Profile

RegenETP, Inc.

RegenETP, Inc., a leading innovator in regenerative medicine, is headquartered in the United States and operates across key regions globally. Founded in 2017, the company has rapidly established itself within the biotechnology industry, focusing on advanced cellular therapies and tissue regeneration solutions. RegenETP is renowned for its proprietary products, which leverage cutting-edge technology to enhance healing processes and improve patient outcomes. Their unique approach to regenerative treatments sets them apart in a competitive market, positioning them as a trusted partner in healthcare innovation. With a commitment to scientific excellence and patient care, RegenETP has achieved significant milestones, including successful clinical trials and partnerships with major healthcare institutions, solidifying its reputation as a frontrunner in the field of regenerative therapies.

DitchCarbon Score

How does RegenETP, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

RegenETP, Inc.'s score of 18 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

RegenETP, Inc.'s reported carbon emissions

RegenETP, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the company may still be engaged in industry-standard practices aimed at reducing carbon footprints and addressing climate change, although details on such initiatives are not provided. As the climate landscape evolves, RegenETP, Inc. may develop and disclose future commitments to enhance transparency and accountability in their environmental performance.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. RegenETP, Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. RegenETP, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

RegenETP, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

Osiris Therapeutics, Inc.

US
Health and social work services (85)
Updated about 1 month ago
DitchCarbon Score

Organogenesis Holdings Inc.

US
Health and social work services (85)
Updated 17 days ago

Vericel Corporation

US
Health and social work services (85)
Updated 14 days ago

AVITA Medical, Inc.

US
Health and social work services (85)
Updated 14 days ago

MiMedx Group, Inc.

US
Health and social work services (85)
Updated 14 days ago

Musculoskeletal Transplant Foundation

US
Health and social work services (85)
Updated 21 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers